Repeated angiograms to achieve an exactly orthogonal visualization of the aortic valve plane can substantially contribute to the total contrast amount required for transcatheter aortic valve implantation (TAVI). We investigated whether preprocedural identification of an optimal fluoroscopic projection by cardiac computed tomography (CT) can significantly reduce the amount of a procedure-related contrast agent compared with angiographic determination of suitable angulations.
Introduction
Transcatheter aortic valve implantation (TAVI) has emerged as treatment of choice for symptomatic severe aortic stenosis in patients with high operative risk. 1, 2 Acute kidney injury (AKI) significantly increases mortality in TAVI patients. Depending on comorbidities, incidence of AKI ranges from 8 to 57%. 3 Periods of poor renal perfusion due to rapid pacing, cholesterol embolization, and iodinated contrast application contribute to the risk of AKI. 4 One crucial step of the TAVI procedure that typically requires repeated contrast injections is the identification of a fluoroscopic projection that provides an exactly orthogonal view of the aortic valve plane. Generally, a projection that displays the right coronary cusp centred between the left and non-coronary cusps of the aortic valve is preferred. 5 Such a projection can be determined periprocedurally by repeated aortograms, with an initial angulation of left anterior oblique (LAO) 108 and cranial 108 suggested by Kasel et al. 6 However, repeated aortograms require repetitive injections of the contrast agent.
Computed tomography (CT) is an important imaging modality for the workup of patients who are under consideration for TAVI. 5 It has previously been suggested that CT can be used to predict a suitable projection that renders an orthogonal view onto the aortic valve plane. 5,7 -12 So far, it has not been evaluated in a randomized fashion whether the use of CT leads to a change in procedural parameters, most importantly a decreased volume of contrast agent. We therefore conducted a prospective, randomized trial to evaluate whether CT-based prediction of a suitable fluoroscopic angulation for TAVI is associated with a change in procedural parameters, with procedural contrast volume as the primary outcome measure.
Methods Patients
A total of 199 consecutive patients scheduled for TAVI between March 2014 and September 2015 were screened for enrolment. Exclusion criteria were a transapical access route (14 patients), an estimated glomerular filtration rate (eGFR) ,50 mL/min before the procedure (required by the Institutional Review Board), documented prior renal failure or renal replacement therapy (70 patients), use of a valve type other than Edwards Sapien 3 (Edwards Lifesciences Inc., Irvine, CA, USA) (14 patients), a valve-in-valve procedure (11 patients), prior valvuloplasty (3 patients), and a congenitally bicuspid aortic valve (1 patient). Four patients were unable to provide informed consent, and two patients refused participation. Finally, 80 patients were included in the study after written consent ( Figure 1) . The study was approved by the Institutional Review Board (reference number: 27_14B). Covariates, including cardiac history and risk factors, were obtained by a structured interview. The EuroSCORE II was calculated in all patients. 13 Echocardiography was performed in all patients within 7 days before and after the TAVI procedure. Serum creatinine, eGFR, and haemoglobin were measured the day before the procedure, immediately after the procedure, the following day, and every other day until the postprocedural day 7. The classification of induced AKI was based on the RIFLE/AKIN criteria, and the additional parameter 'urine output' was disregarded because of the heterogeneity of volume status and diuretic use in these patients. 14 The maximal RIFLE stage for serum creatinine level and eGFR during the first 7 days was documented. In-hospital complications and mortality were documented. The 30-day mortality was assessed by a telephone interview.
CT image acquisition
Pre-procedural CT imaging was performed in all 80 patients using a third-generation dual-source CT (Somatom Force; Siemens Healthcare, Forchheim, Germany) to analyse vascular access as well as aortic annulus geometry and diameters. The mean time interval between CT and TAVI was 36 days. A prospectively ECG-triggered high-pitch spiral acquisition (250 ms gantry rotation, 66 ms temporal resolution, 2 × 196 × 0.6 collimation, tube voltage 120 kV, tube current 350 -500 mA s depending on weight) was performed. Scan direction was cranio-caudal from above the aortic arch to below the hip. Image acquisition was timed so that the level of the left main coronary artery would be imaged at 60% of the R-peak to R-peak interval. Acquisition was performed in deep inspiration with arms raised. The contrast agent transit time was measured using the test bolus technique (10 mL of the Figure 1 Study flow chart and reasons for exclusions. Out of the 199 consecutive patients screened for participation in the study, we included 80 patients in the final cohort.
contrast agent followed by a saline flush of 50 mL, a flow rate of 5 mL/s). For CT angiography, 50 mL of the contrast agent (350 mg iodine/mL) were injected in an antecubital vein with a flow rate of 5 mL/s, followed by a 60 mL flush consisting of 80% saline and 20% contrast agent. Images were reconstructed using a medium sharp kernel ('Bv40'), a slice thickness of 0.6 mm, and an increment of 0.4 mm.
CT image analysis
Analyses were performed on a dedicated off-line workstation (Multimodality Workplace, Siemens Healthcare). Suitable fluoroscopic angulations were determined by a cardiologist with several years of cardiac CT experience and more than 300 previously interpreted patient data sets in the context of TAVI. To create a double-oblique plane of the aortic annulus, the lowest insertion points of the right, left, and non-coronary aortic valve cusps were aligned by stepwise manipulation of multiplanar reconstructions as previously described. 10 From this initial position, the plane was shifted cranially to the level of the aortic valve commissures, and the angulation of an image plane that is orthogonal both to the aortic annulus plane and to the commissural line between the left and non-coronary aortic valve was determined ( Figure 2 ). The extent of calcification of the aortic valve cusps and the commissures was determined using separate four-step visual scales for the aortic valve cusps (0: no calcifications, 1: one or several lesions ,5 mm or one lesion .5 mm, 2: two to three lesions .5 mm, and 3: more than three lesions .5 mm) and commissures (0: no calcification, 1: single lesions ,5 mm, 2: lesions .5 mm or affecting two or more leaflets, and 3: severe calcification affecting all three leaflets). 15 
TAVI procedure
The TAVI procedure was performed under general anaesthesia in a hybrid operating suite by an interdisciplinary team of interventional cardiologists and cardiac surgeons with more than 500 jointly performed previous procedures. Intravenous fluids were administered pre-, peri-, and post-procedurally. Patients were positioned supine without LAO/ RAO angulation. All pre-implantation aortograms were performed with injection of 15 mL contrast agent (350 mg iodine/mL, flow rate 10 mL/s) via a pigtail catheter in the ascending aorta. Prior to the procedure, patients were randomized in a 1:1 fashion. In 40 patients randomized to the CT cohort, the operator acquired the first aortogram using the CT-determined angulation. In the 40 control patients (angiography cohort), operators were blinded to the CT-determined angulation and LAO 108/cranial 108 was used for the first aortogram. If the operators considered the first aortographic projection appropriate, this angulation was used for the further procedure. Otherwise, repeated aortograms were performed with modification of the C-arm angulation in 108 increments according to the 'follow the right cusp' rule (6) until a satisfactory angulation was achieved. After balloon valvuloplasty, the prosthesis was implanted under rapid pacing. At least one post-implantation aortogram was acquired. In the case of remaining paravalvular regurgitation, additional balloon expansions were performed at the discretion of the operators. A final aortogram with a total contrast volume of 30 mL (flow rate 15 mL/s) was performed to determine the degree of postprocedure aortic regurgitation (grades 1 -4). 15, 16 Valve malposition was defined as present if an inadequate position of the device required the implantation of a second valve or emergent surgery.
The following procedural parameters were documented: number of aortograms until a satisfactory angulation was found, contrast volume, fluoroscopy time, dose area product, duration from cut to suture, postimplantation balloon valvuloplasty, and final grade of angiographically assessed aortic regurgitation. The primary endpoint was contrast volume used during the procedure.
Statistics
Statistical analysis was performed using SPSS software (version 21; IBM w SPSS w statistics, Armonk, NY, USA). Continuous variables were expressed as mean and standard deviation, categorical variables as frequencies and percentage, unless otherwise specified. A x 2 -test was used for comparison between categorical variables. For binary analysis, normally distributed data were compared using t tests and nonparametric data using Mann -Whitney U-test for continuous variables.
All tests were performed two-sided. P , 0.05 was considered to be statistically significant.
Results

Baseline characteristics and outcome
The mean patient age was 81 + 5 years, and 55% of the patients were male. The mean baseline creatinine level was 0.96 + 0.21 mg/dL, the mean baseline eGFR was 73. 
Fluoroscopic angulation and number of required aortic angiograms
The number of aortic angiograms needed to achieve a satisfactory fluoroscopic position was significantly lower in the CT cohort compared with the angiography cohort (1.2 + 0.6 vs. 3.2 + 1.7; P , 0.001). In the CT cohort, 4/40 (10%) patients required at least one further aortogram, whereas there were 35/40 (88%) patients with at least two aortic angiograms in the angiography cohort ( 
were not different between patients in the CT cohort requiring at least two aortograms vs. only one aortogram ( Table 3) . The total procedural amount of the contrast agent was significantly lower in the CT cohort compared with the angiography cohort (95 + 21 vs. 125 + 36 mL; P , 0.001, Figure 4 ).
Procedural parameters
There were no significant differences in the dose area product (6072 + 2821 vs. 6821 + 2600 cGy cm 2 
Renal function
AKI occurred in nine patients (11%) within the first seven postprocedural days with no significant difference between the two cohorts (seven in the CT cohort vs. two in the angiography cohort; P ¼ 0.077) ( Table 2 ). All acute kidney injuries were classified as class 'risk'. There was no need to perform haemodialysis in any patient. 
Discussion
In a prospective randomized study, we evaluated a CT-based method for the prediction of suitable angulations to achieve orthogonal projections of the aortic annulus plane for the TAVI procedure against the widely used 'follow the right cusp' rule by Kasel et al., a step-by-step approach of repeated angiograms with an initial angulation of LAO 108/cranial 108. 6 A significant reduction in the number of required aortograms and the amount of administered contrast medium were found for the CT cohort compared with the angiography cohort. Importantly, the CT-based approach for finding a suitable angulation showed no difference in terms of peri-or post-procedural complications. Several CT-based approaches for pre-procedural identification of the orientation of the aortic annulus plane and prediction of an appropriate projection angle have been described. 8, 9, 11, 12 They often aimed to determine a line of perpendicularity of the aortic annulus and the C-arm position. Our method identifies a single 'optimal' projection angle that will render the right coronary cusp in the centre, with the left and the non-coronary cusps symmetrically behind it. High inter-and intraobserver agreement has been reported for this method. 17 An incorrect prediction of a suitable angulation based on CT occurred in only 10% of the cases. Given the small number of incorrect predictions, we could not identify any angulation prone for disconcordance of CT-predicted angulation and final fluoroscopy plane.
Samim et al. applied a dedicated software to define the line of perpendicularity and the position of the C-arm was chosen among the various positioning possibilities proposed by CT analysis in a nonrandomized historical control collective with a pronounced learning curve including 36 patients in the CT group and 11 patients in the angiography cohort. 8 Importantly, in contrast to our study, they did not perform any test angiography of the aortic root for validation of the predicted angulation before prosthesis placement. The contrast agent was only administered to examine the height of the endoprosthesis relative to the annulus. There was one case out of 36 patients with inaccurate alignment of the annulus in whom the prosthesis had to be repositioned before delivery. In-hospital mortality (n, %) 0 (0) 0 (0) 0 (0) 1.000 30-Day mortality (n, %) 0 (0) 0 (0) 0 (0) 1.000 BMI, body mass index; NYHA, New York Heart Association; CAD, coronary artery disease; eGFR, estimated glomerular filtration rate.
a Implantation of a permanent pace maker within 30 days after the TAVI procedure; 7 patients had an pacemaker/ICD prior to the TAVI procedure.
Gurvitch et al. reported accurate prediction of the line of perpendicularity in only 50% in a cohort of 20 patients. 9 The extent of aortic valve calcification as well as the image quality have been suggested to influence the prediction's success in previous studies. 7, 9 We could not confirm these findings in our study-this may have been due to small numbers with only four patients with incorrect CT-based prediction. Acute kidney failure subsequent to the TAVI procedure has been identified as a major predictor of mortality. 3 Previous studies
showed an association of prior chronic renal failure, peri-procedural bleeding and blood transfusion, transapical access route, peripheral vascular disease, and arterial hypertension with the occurrence of AKI following TAVI. 4,18 -20 The association between larger volumes of the iodinated contrast agent and the likelihood of contrast-induced nephropathy has been shown severalfold for coronary interventions, but only a few studies have reported a relationship between contrast volume and AKI occurrence in TAVI patients. 8, 18, 21, 22 Here, we observed acute kidney failure in 11% of patients during the first seven post-procedural days. However, and again possibly due to low numbers, the rate did not significantly differ between the CT and the angiography cohort. We observed that a higher BMI and diuretics as part of baseline medication were associated with the occurrence of AKI. There was no need for renal replacement therapy in any patient. As we only included patients with normal renal function and limited our analysis to TAVI performed via the transfemoral access route, the incidence of AKI was rather low in our study compared with previous reports ranging between 8 and 57%. 3 In contrast to our results, Samim et al.
reported a significant decrease in the incidence of post-procedural AKI. 8 The mean amount of the contrast agent in the CT cohort and, especially, the angiography cohort of this study was higher compared with our study (108 vs. 95 mL for the CT cohort and 180 vs. 125 mL for the angiography cohort). It has to be further considered that Samim et al. enrolled patients independently from their renal function and from the access route, both are independent predictors for the occurrence of AKI in TAVI patients. A transapical approach was used in 50% of patients in the angiography cohort and only 28% of patients in the CT. This was due to the study design that relied on historical controls and therefore included a procedural learning curve.
Some procedural risks including annulus rupture, coronary occlusion, post-procedural severe aortic regurgitation or incorrect positioning of the prosthesis in TAVI may be related to an incorrect fluoroscopic angulation. 23, 24 In our cohort, CT-based prediction was not associated with an increase in severe complications. We did not observe any major complications, and the incidence of minor complications in our relatively low-risk cohort was 24%.
There was no in-hospital death or mortality within 30 days. Compared with previous studies, we therefore observed a lower rate of complications and mortality. 25 This is most likely due to the fact that only patients with normal renal function and with a transfemoral access were enrolled.
Limitations
The current study was performed at a single centre with high expertise both in the TAVI procedure and cardiac CT. Results may not be immediately transferrable to sites with less routine in cardiac CT. Inclusion was limited to patients with a transfemoral approach and the implantation of the balloon-expandable Sapien 3 valve prosthesis. We further only included patients with normal baseline renal function. While in such patients contrast reductions may be least relevant, there is no reason to assume that our results regarding the reduction of necessary aortograms and contrast volume would not be transferrable to patients with impaired kidney function. Because of the limited number of patients, we were not able to demonstrate significant differences in other parameters, such as procedure time and radiation dose.
Conclusions
Pre-procedural identification of a fluoroscopic projection by cardiac CT allows a significant reduction in the volume of peri-procedural contrast agent compared with an angiography-based approach without an increase of complications.
